Immune profiling leads to implications for immunotherapy for NF1-associated tumors – EurekAlert (press release)
|
Immune profiling leads to implications for immunotherapy for NF1-associated tumors
EurekAlert (press release) Neurofibromatosis type 1 (NF1) — an autosomal dominant disorder affecting approximately one in every 3,500 people — results in dysfunctional neurofibromin, a protein expressed throughout the body and involved in the RAS signaling pathway. Virtually … |
